These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11494150)

  • 21. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
    Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
    Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
    Page C; Lin HJ; Jin Y; Castle VP; Nunez G; Huang M; Lin J
    Anticancer Res; 2000; 20(1A):407-16. PubMed ID: 10769688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation.
    Guijarro MV; Link W; Rosado A; Leal JF; Carnero A
    Carcinogenesis; 2007 Dec; 28(12):2443-50. PubMed ID: 17675338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning.
    Uchiyama T; Engelman RM; Maulik N; Das DK
    Circulation; 2004 Jun; 109(24):3042-9. PubMed ID: 15184284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
    Humar R; Kiefer FN; Berns H; Resink TJ; Battegay EJ
    FASEB J; 2002 Jun; 16(8):771-80. PubMed ID: 12039858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
    Brondyk WH; Boeckman FA; Fahl WE
    Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation.
    Bellosta P; Zhang Q; Goff SP; Basilico C
    Oncogene; 1997 Nov; 15(20):2387-97. PubMed ID: 9395235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src activation regulates anoikis in human colon tumor cell lines.
    Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
    Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.
    Romashkova JA; Makarov SS
    Nature; 1999 Sep; 401(6748):86-90. PubMed ID: 10485711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells.
    Sun SY; Yue P; Shroot B; Hong WK; Lotan R
    Oncogene; 1999 Jul; 18(26):3894-901. PubMed ID: 10445853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.
    Ramana CV; Grammatikakis N; Chernov M; Nguyen H; Goh KC; Williams BR; Stark GR
    EMBO J; 2000 Jan; 19(2):263-72. PubMed ID: 10637230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciliary transport regulates PDGF-AA/αα signaling via elevated mammalian target of rapamycin signaling and diminished PP2A activity.
    Umberger NL; Caspary T
    Mol Biol Cell; 2015 Jan; 26(2):350-8. PubMed ID: 25392303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
    Wu W; Fan YH; Kemp BL; Walsh G; Mao L
    Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-myc-Dependent hepatoma cell apoptosis results from oxidative stress and not a deficiency of growth factors.
    Xu Y; Nguyen Q; Lo DC; Czaja MJ
    J Cell Physiol; 1997 Feb; 170(2):192-9. PubMed ID: 9009148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase.
    Jeay S; Sonenshein GE; Kelly PA; Postel-Vinay MC; Baixeras E
    Endocrinology; 2001 Jan; 142(1):147-56. PubMed ID: 11145577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis.
    Greenland C; Touriol C; Chevillard G; Morris SW; Bai R; Duyster J; Delsol G; Allouche M
    Oncogene; 2001 Nov; 20(50):7386-97. PubMed ID: 11704868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.